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ABSTRACT
Acute metabolic encephalopathy is potentially a reversible condition and requires an early diagnosis and management
to reduce morbidity and mortality, as in under diagnosed patients, permanent damage can result. Diabetic encephalopathy is an emerging complication of both type I and type II diabetes. Besides T1 hperintensities in bilateral basal
ganglia in diabetic encephalopathy patients, reported in most of the literature reviewed, patients with hyperglycemic
seizures can present with subcortical hyperintensities , with predilection for occipital lobes. Here, we report a case of
type II diabetic, 40 year-female patient who was referred for MR brain to our department, presented with acute symptoms of delirium, headache and fits, increased serum glucose levels at time of presentation. No T1 hyperintensities
were identified in basal ganglia, instead the variable pattern of subcortical hyperintensities were identified with postcontrast patchy and gyriform enhancement. She was diagnosed with metabolic encephalopathy and referred back to
referring clinician for adequate management. On follow up, patient improved clinically with insulin therapy. This report
highlights the importance of early diagnosis of diabetic encephalopathy in patients with variable patterns on MR
imaging , thus to avoid unnecessary medical treatment and prevent irreversible symptoms.
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Introduction:

headache for 4 days, delirium for 3 days and fits for 2
days. Fits initially begin in right upper limb which gradually progresses and involve whole body with uprolling of
eyes and frothing from mouth (described as focal
seizures with secondary generalization). Her neurological examination showed normal tone and bulk, reduce
power in all four limbs and up going plantars bilaterally.
Her blood pressure was within normal limits 120/80
mm Hg. Blood arterial gas analysis was normal with pH
7.5, pCO2 23.7, pO2 141, HCO3, Sat O2 and lactate
1.4. Her blood biochemistry showed increased glucose
levels of 180 mg/dl and HbA1c of 12 mg%. Complete
blood count and Electrolytes were within normal limits
with normal EEG. Her urine analysis was negative for
ketones. She received stat doses of I/V antibiotics in
emergency, which were stopped when blood cultures
came to be negative. She was referred for MR brain for
further evaluation, which demonstrated T1 and T2
isointense signals with FLAIR hyperintensities in cortical
and subcortical region of right posterior parietooccipital lobes, showing linear as well as gyriform

Encephalopathy is the state of diffuse cerebral dysfunction, secondary to systemic causes, metabolic derangements or drug toxicities. Diabetic encephalopathy has
shown increased in the incidence as the incidence of
type I diabetes has increased in recent years (1).
Clinical presentation is variable, with the delirium being
the most common presentation. Besides clinical evaluation and laboratory analysis of arterial blood gases and
blood biochemistry, somatosensory evoked potential
(SSEP), electroencephalography (EEG), and imaging
methods like multislice spiral computed tomography
(MSCT) and magnetic resonance imaging (MRI) are
also required (2).
Case Report:
We report a known case of, 40 year female afebrile
patient with uncontrolled type II diabetes on oral
hypoglycemic drugs for ten years, presented with
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ment on postcontrast images. These show restriction in
Diffusion weighted images. Posterior reversible
encephalopathy syndrome(PRES) and metabolic
encephalopathy were included in differential diagnosis.
PRES was excluded as patient’s blood pressure was
within normal limits and there was no clinical history of
high blood pressures. Furthermore T2 isointense
signals and post contrast gyriform enhancement do
not favour PRES. Keeping in view the clinical history of
patient, metabolic encephalopathy was considered the
top diagnosis despite variable pattern of MR brain
features. Patient was managed accordingly and
followed during the course of the treatment which
showed resolution of the signs and symptoms. Patient
was discharged due to which repeat MR brain could
not be performed.

Discussion:
Kinner Wilson, in 1912, defined metabolic encephalopathy for the first time as the state of global cerebral
dysfunction caused by systemic stress, which has
variable manifestation from a very mild disorder to deep
coma with decerebrate rigidity. It has been defined as
diffuse cerebral dysfunction as well as a systemic
disorder affecting hemispheres, reticular activating
system and brainstem causing diffuse brain
damage(2).
There are multiple causes for metabolic ‘encephalopathy which include chronic organ diseases, electrolyte
imbalances, hypo- or hyperglycemia, osmotic
disorders, overdose of medications especially in
intensive care units, multiple drug toxicity, alcohol or
toxin abuse.
Neuroimaging including CT or MRI are important to
exclude any organic or structural lesions of the brain.
Patients with encephalopathy have usually normal CT
and MRI brain. However, diffuse or focal edema,
changes in the signal intensities in certain regions can
provide clue to the diagnosis and underlying extracerebral pathology. Basal ganglia, thalamus, cerebral
cortex, and hemispheric white matter are usually the
target regions in metabolic encephalopathy.
To the best of the author’s knowledge, literature review
shows the characteristic appearance of nonketotic
hyperglycemia (NKHG) is unilateral or asymmetrical
bilateral lesions of the basal ganglia which are contralateral to the side of the patient’s presenting symptoms.
Similarly, on non-enhanced CT brain, putamen and /
caudate nucleus show hyperdensities contralateral to
the side of patient’s symptoms (3).

Figure 1 : a-T1WI, b-T2WI, c-d FLAIR images.

Suárez-Vega VM et al. (4) reported rare case of Nonketotic hyperglycemic hemichorea-hemiballism (NHH)
causing unilateral brain abnormalities, affecting basal
ganglia and subtle hyperdensity in striatal region on CT
scan of brain and T1 hyperintensity and T2 hypointensity in the basal ganglia contralateral to the movements
on MR imaging.
Hyperglycemic seizures are more commonly seen in
Non-Ketotic hyperglycemia (NKHG). Seizures can be
focal with or without secondary generalization and
occasionally occipital lobe seizures or epilepsia partialis
continua (5). As seen in our patient, she suffered from
focal seizures with secondary generalization.

Figure 2: a-c post contrast images, d-DW image.
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Conclusion:

tion secondary to the ictus can be seen. However,
Subcortical areas of T2 hyperintensities are seen in
subset of NKHG patients. The affected regions show T1
isointense, focal T2 hypointensity in the cortex but
T2/FLAIR hyperintensities in underlying white matter
with associated cortical swelling can also be seen.
Gradient echo images also demonstrate subcortical
hypointense signals. ADC values are transiently
reduced, with focal cortical and leptomeningeal
enhancement. In follow up scans, these can be either
completely resolved or present as focal gliosis.

Diabetic encephalopathy is a potentially reversible
acute metabolic encephalopathy requires an early
accurate diagnosis, to plan appropriate management.
Clinical background of poorly controlled diabetes with
hyperglycemia, focal seizures with or without secondary
generalization, in appropriate CT and MR findings are
helpful to clinch the diagnosis. This report emphasizes
the importance of metabolic causes of encephalopathy
thus facilitating the prompt and appropriate management.

There is predilection for occipital lobes along with
parietal, temporal and perirolandic cortex. These foci
correlate with the ictal focus on EEG, which regresses
with correction of hyperglycemia. Patients usually have
elevated HbA1C levels.
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